To test the effect of Sgt1 reduction on tumorigenicity, we conducted an allograft experiment in which Hras-transduced Sgt1+/+p53−/− and Sgt1+/−p53−/− MEF cells were injected into immunodeficient mice and tumor formation was monitored. The gene discussed is HRAS; the disease is neoplasm.